Arthroplasty, Replacement, Knee Clinical Trial
Official title:
A Double Blind, Randomized Clinical Trial Comparing Postoperative Narcotic Usage in Patients Receiving Periarticular Liposomal Bupivicaine vs. Those Patients Receiving Standard Periarticular Joint Injections
Verified date | July 2017 |
Source | University of California, Irvine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study seeks to determine whether a new sustained-release local anesthetic solution (Exparel - Liposomal Bupivacaine) injected into the soft tissues around the joint after surgery will decrease opioid consumption and adverse events in opioid-tolerant patients presenting for total knee arthroplasty. The research hypothesis is that the Exparel (study) group will use less opioid in the first 48 hours post-operatively than the control group.
Status | Completed |
Enrollment | 38 |
Est. completion date | August 2015 |
Est. primary completion date | July 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Males and Females age 18+ years old having total knee arthroplasty at UCI - Meet at least one of the following criteria "opioid tolerant": - Taking 50mg oral morphine equivalent or more per day - On long-acting opioids (fentanyl pathc, oxycontin, methadone, etc.) - Being followed by a chronic pain physician - All subjects must be free of renal or hepatic dysfunction; defined as: - Glomerular filtration rate >60 mL/min/1.73m^2 - AST & ALT <150, total bilirubin <1.0, INR <1.3 (if not taking anticoagulants) - No active hepatitis, no jaundice Control group- received standard periarticular injection Research group- receives Exparel injection Exclusion Criteria: - Allergy to local Anesthetic - Pregnancy - Nursing mothers - Children<18 years of age - Renal impairment (GFR<60 mL/min/1.73 m^2 - Hepatic impairment (active hepatitis, elevated AST or ALT, jaundice) - Any history of ventricular arrhythmia or supraventricular tachycardia, or myocardial infarction within the last six months. |
Country | Name | City | State |
---|---|---|---|
United States | UC Irvine Medical Center | Orange | California |
Lead Sponsor | Collaborator |
---|---|
University of California, Irvine |
United States,
Bergese SD, Ramamoorthy S, Patou G, Bramlett K, Gorfine SR, Candiotti KA. Efficacy profile of liposome bupivacaine, a novel formulation of bupivacaine for postsurgical analgesia. J Pain Res. 2012;5:107-16. doi: 10.2147/JPR.S30861. Epub 2012 May 1. — View Citation
Candiotti K. Liposomal bupivacaine: an innovative nonopioid local analgesic for the management of postsurgical pain. Pharmacotherapy. 2012 Sep;32(9 Suppl):19S-26S. doi: 10.1002/j.1875-9114.2012.01183.x. — View Citation
Chahar P, Cummings KC 3rd. Liposomal bupivacaine: a review of a new bupivacaine formulation. J Pain Res. 2012;5:257-64. doi: 10.2147/JPR.S27894. Epub 2012 Aug 14. — View Citation
Chen Y, Zhang Y, Zhu YL, Fu PL. Efficacy and safety of an intra-operative intra-articular magnesium/ropivacaine injection for pain control following total knee arthroplasty. J Int Med Res. 2009 Nov-Dec;37(6):1733-41. Corrected and republished in: J Int Med Res. 2012;40(5):2032-40. Retraction in: J Int Med Res. 2012;40(5):2031. — View Citation
Cohen SM. Extended pain relief trial utilizing infiltration of Exparel(®), a long-acting multivesicular liposome formulation of bupivacaine: a Phase IV health economic trial in adult patients undergoing open colectomy. J Pain Res. 2012;5:567-72. doi: 10.2147/JPR.S38621. Epub 2012 Nov 20. — View Citation
Fu P, Wu Y, Wu H, Li X, Qian Q, Zhu Y. Efficacy of intra-articular cocktail analgesic injection in total knee arthroplasty - a randomized controlled trial. Knee. 2009 Aug;16(4):280-4. doi: 10.1016/j.knee.2008.12.012. Epub 2009 Mar 18. — View Citation
Grant GJ, Barenholz Y, Bolotin EM, Bansinath M, Turndorf H, Piskoun B, Davidson EM. A novel liposomal bupivacaine formulation to produce ultralong-acting analgesia. Anesthesiology. 2004 Jul;101(1):133-7. — View Citation
Grant GJ, Piskoun B, Bansinath M. Analgesic duration and kinetics of liposomal bupivacaine after subcutaneous injection in mice. Clin Exp Pharmacol Physiol. 2003 Dec;30(12):966-8. — View Citation
Huxtable CA, Roberts LJ, Somogyi AA, MacIntyre PE. Acute pain management in opioid-tolerant patients: a growing challenge. Anaesth Intensive Care. 2011 Sep;39(5):804-23. Review. — View Citation
Patanwala AE, Jarzyna DL, Miller MD, Erstad BL. Comparison of opioid requirements and analgesic response in opioid-tolerant versus opioid-naïve patients after total knee arthroplasty. Pharmacotherapy. 2008 Dec;28(12):1453-60. doi: 10.1592/phco.28.12.1453. — View Citation
Richard BM, Newton P, Ott LR, Haan D, Brubaker AN, Cole PI, Ross PE, Rebelatto MC, Nelson KG. The Safety of EXPAREL ® (Bupivacaine Liposome Injectable Suspension) Administered by Peripheral Nerve Block in Rabbits and Dogs. J Drug Deliv. 2012;2012:962101. doi: 10.1155/2012/962101. Epub 2012 Jan 17. — View Citation
Richard BM, Rickert DE, Newton PE, Ott LR, Haan D, Brubaker AN, Cole PI, Ross PE, Rebelatto MC, Nelson KG. Safety Evaluation of EXPAREL (DepoFoam Bupivacaine) Administered by Repeated Subcutaneous Injection in Rabbits and Dogs: Species Comparison. J Drug Deliv. 2011;2011:467429. doi: 10.1155/2011/467429. Epub 2011 Oct 5. — View Citation
Urban MK, Ya Deau JT, Wukovits B, Lipnitsky JY. Ketamine as an adjunct to postoperative pain management in opioid tolerant patients after spinal fusions: a prospective randomized trial. HSS J. 2008 Feb;4(1):62-5. doi: 10.1007/s11420-007-9069-9. Epub 2007 Dec 19. — View Citation
Zywiel MG, Stroh DA, Lee SY, Bonutti PM, Mont MA. Chronic opioid use prior to total knee arthroplasty. J Bone Joint Surg Am. 2011 Nov 2;93(21):1988-93. doi: 10.2106/JBJS.J.01473. — View Citation
* Note: There are 14 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | 48 Hour Post-surgical Opioid Use | A comparison of group means between the control group and study group with regards to 48 hour opioid use. | 48 hours | |
Secondary | Recovery Room Opioid Use | Post anesthesia care unit (recovery room) opioid use in total mg morphine IV equivalent in comparison of standard knee injection post-operatively. | Up to 48 hours | |
Secondary | Average Daily Opioid Use During Admission | Opioid use will be monitored daily from the time of admission in comparison of standard knee injection post-operatively. | Up to 48 hours | |
Secondary | Average Daily Patient Pain Score | Examining the average daily patient pain score in comparison of standard knee injection post-operatively. The measure is the Visual-Analog-Scale (VAS) for subjective pain reporting. The minimum 0 (no pain) and the maximum is 10 (worst pain imagineable). There is only one measure in the scale (i.e. there are no subscales). Lower scores on the VAS scale equate to less pain and are therefore desirable. | Up to 48 hours | |
Secondary | Post-operative Complications | Examining the post-operative complication in comparison of standard knee injection post-operatively. | Up to 1 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
Recruiting |
NCT05002387 -
Diagnostic Knee Needle Arthroscopy in Predicting Unicompartmental Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT06080763 -
Biomechanics and Clinical Outcomes in Responders and Non-Responders
|
||
Completed |
NCT03008967 -
A Study of Patients Undergoing Total Knee and Hip Arthroplasty at a Regional Hospital in Denmark
|
N/A | |
Withdrawn |
NCT02255877 -
ZIPS Study - Zip Incision Approximation vs. STAPLE
|
Phase 4 | |
Completed |
NCT02642731 -
Kidney Biomarkers of Acute Kidney Injury in Patients With Knee Arthroplasty
|
N/A | |
Completed |
NCT02525588 -
Polyethylene Wear Study on the Triathlon Total Knee Prosthesis
|
N/A | |
Completed |
NCT01799772 -
The Feasibility of a Comprehensive Behavioral Intervention in Patient Post TKA
|
Phase 1/Phase 2 | |
Completed |
NCT02520531 -
Scorpio Posterior Stabilised (PS) vs Scorpio NRG ("Energize") PS - Total Knee Arthroplasty
|
N/A | |
Completed |
NCT03183856 -
Comparison of Ambulatory and Functional Improvement by Morning Walk
|
N/A | |
Completed |
NCT03569397 -
Music Therapy Versus Control for Total Knee Arthroplasty
|
N/A | |
Terminated |
NCT02711592 -
Pharmacogenomics Information in Enhancing Post-operative Total Joint Replacement Pain Management: a Pilot Study
|
N/A | |
Completed |
NCT03145493 -
Effect of Suction Drains in Total Knee Arthroplasty With Tranexamic Acid
|
N/A | |
Terminated |
NCT05602701 -
Preoperative Prediction of Postoperative Physical Function
|
||
Recruiting |
NCT03570944 -
Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol (POWER2)
|
||
Completed |
NCT02773537 -
Motor-Sparing Peripheral Nerve Blockade Facilitates Mobility Post Total Knee Arthroplasty: A Randomized Controlled Trial
|
N/A | |
Withdrawn |
NCT02553122 -
The Combined Efficacy of Evicel and Tranexamic Acid on Total Knee Arthroplasty
|
Phase 3 | |
Recruiting |
NCT02385383 -
An Intravenous Iron Based Protocol for Preoperative Anaemia in Hip and Knee Surgery - An Observational Study
|
N/A | |
Terminated |
NCT02155712 -
Triathlon Tritanium Knee Outcomes Study
|
N/A | |
Completed |
NCT02121392 -
Epidural Catheter With or Without Adductor Canal Nerve Block for Postoperative Analgesia Following Total Knee Arthroplasty
|
N/A |